Assessing human error rates in strabismus surgery

Article

Sensitivity analysis could determine the rate of human error in strabismus surgery and reduce the need for repeated operations, according to results published online ahead of print by Graefe's Archive for Clinical and Experimental Ophthalmology.

Sensitivity analysis could determine the rate of human error in strabismus surgery and reduce the need for repeated operations, according to results published online ahead of print by Graefe's Archive for Clinical and Experimental Ophthalmology.

Sander Schutte of the Department of BioMechanical Engineering, Faculty of Mechanical, Maritime and Materials Engineering, Delft University of Technology, Delft, The Netherlands and colleagues employed a variety of methods to investigate how to improve human-error influenced outcomes of strabismus surgery, including angle measurement, surgical strategy and accuracy. The influence of each of these factors underwent sensitivity analysis, and the results were compared with clinical trials.

The team found that it was possible to map desirable surgery trajectories mathematically, and that surgical recessions varied from the optimal trajectory by as much as 20%.

Thus the team concluded that quantifying the level of human error during strabismus surgery with sensitivity analysis could increase the accuracy of the measurement of the angle to be corrected, decrease the variability of trajectory and lead to more accurate surgery, thereby decreasing the need for repeated surgical interventions.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.